In NPC, NLRP3, AIM2 and RIG-I inflammasomes were overexpressed in the tumour cells and were required for IL-1β production in response to PAMPs and DAMPs in the tumour microenvironment and therapeutic treatment. The gene discussed is IL1B; the disease is neoplasm.